Muncy Columbia director buys CCFN shares at $59.55
Muncy Columbia Financial Corp director Robert J. Glunk reported multiple open‑market purchases of common stock on January 27, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Muncy Columbia Financial Corp director Robert J. Glunk reported multiple open‑market purchases of common stock on January 27, 2026. The transactions, coded as purchases, involved small blocks of 8, 25, 25, 10, 9 and 9 shares at a price of $59.55 per share.
These shares are held indirectly in various accounts listed as "As custodian", while he also reports a separate direct holding of 26,995.13 common shares following the transactions. No derivative securities were reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common | 8 | $59.55 | $476.40 |
| Purchase | Common | 25 | $59.55 | $1K |
| Purchase | Common | 25 | $59.55 | $1K |
| Purchase | Common | 10 | $59.55 | $595.50 |
| Purchase | Common | 9 | $59.55 | $535.95 |
| Purchase | Common | 9 | $59.55 | $535.95 |
| Holding | Common | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did CCFN director Robert J. Glunk report?
Were the January 27, 2026 CCFN insider transactions purchases or sales?
How are the CCFN director’s indirect Muncy Columbia Financial holdings described?
Does the Form 4 report any derivative securities for CCFN’s director?
AI-generated analysis. How Rhea-AI works. Not financial advice.